Tradestie Institutional Equity Comparison Engine

HPK vs VET โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HPK Overall Edge

HPK Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HighPeak Energy, Inc. Common Stock (HPK) driven by superior Growth & Margin, Momentum & Technical while VET counters with relative strength in Valuation, Options & Structure. Fundamentally, HPK trades at 24.4x Forward P/E with 18.8% operating margin (+23.0% YoY revenue) versus VET at 17.4x Forward P/E and -0.7% operating margin (+30.4% YoY). In options structure, HPK sits in BREAKDOWN (82nd %ile IV; Dealer Gamma Walls on Pro) against VET sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VET
HPK 24.4x vs VET 17.4x Fwd P/E
Growth & Margin Winner HPK
Op Margin 18.8% vs -0.7% ยท YoY +23.0% vs +30.4%
Momentum & Technical Winner HPK
1Y +24.0% vs +11.3% ยท 52W Pos 39% vs 35%
Options & Structure Winner VET
BREAKDOWN (82nd %ile IV) vs CONSOLIDATION (23rd %ile IV)
HPK NASDAQ
HighPeak Energy, Inc. Common Stock
Drilling Oil & Gas Wells
$7.07
-0.42% 1D
Market Cap $898.4M
1M Return -36.93%
1Y Return +24.04%
Forward P/E 24.4x
Unified AI Score
72.5 / 100 BUY
Tech 91.0 Fund 73.0 Flow 54.0 Mom 70.0
VET NYSE
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
1M Return -23.79%
1Y Return +11.29%
Forward P/E 17.4x
Unified AI Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HPK +24.04% VET +11.29% Spread: +12.75 pp (HPK Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period HPK Revenue VET Revenue HPK Op. Margin VET Op. Margin Margin Edge
Q3 '25 $830M $1.86B 15.7% 6.7% HPK
Q4 '25 $870M $1.85B -7.5% -0.8% VET
Q1 '26 $860M $2.08B 16.7% 19.6% VET
Q2 '26 $1.09B $2.25B 30.6% 23.9% HPK
Q3 '26 $1.03B $2.44B 27.9% 25.8% HPK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HPK (5) vs VET (5)
Institutional Metric HPK VET Criterion Row Winner
Market Capitalization Scale $898.4M $1.6B Larger Scale VET
Trailing P/E Ratio Valuation 32.7x 17.4x Lower Multiple VET
Forward P/E Ratio Valuation 24.4x 17.4x Lower Multiple VET
Revenue Growth (YoY) Growth +23.0% +30.4% Higher Growth VET
Operating Margin (TTM) Profitability 18.8% -0.7% Higher Margin HPK
Net Profit Margin Profitability -13.8% -24.6% Higher Margin HPK
Return on Equity (ROE) Capital Efficiency -8.1% -20.1% Higher ROE HPK
52-Week Range Position Momentum 39% ($4โ€“$12) 35% ($8โ€“$15) Stronger Trend HPK
Beta / 30D Volatility Risk Regime -0.85ฮฒ ยท 94% Vol -0.77ฮฒ ยท 61% Vol Lower Realized Risk VET
Unified Institutional Score Composite Signal 72.5 / 100 (BUY) 71.1 / 100 (BUY) Higher Composite HPK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HPK vs VET Buy Guide
HPK BREAKDOWN
24d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 82nd %ile
IV Regime Extreme (>80th %ile)
Live HPK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VET CONSOLIDATION
48d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live VET Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HPK nor VET registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.